3170F Baselin flo cytometry b/4 treatment
Also known as: baseline flow cytometry documented, pre-treatment flow cytometry assessment
Performance measure documenting baseline flow cytometry testing performed prior to cancer treatment initiation in patients with hematologic malignancy.
In Plain Language
blood test to check cancer cell types before treatment
Clinical Context
Quality metric tracking appropriate baseline diagnostic testing in hematologic malignancy patients before chemotherapy or other cancer-directed therapy.
RVU Information
CPT 3170F does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Documentation should include the clinical indication, service details, and any applicable performance metrics. Coverage may vary by payer — verify acceptance before billing.
Specialties
Frequently Asked Questions
What is CPT code 3170F?
CPT 3170F (Baselin flo cytometry b/4 treatment) is a Other code. Performance measure documenting baseline flow cytometry testing performed prior to cancer treatment initiation in patients with hematologic malignancy.
Who uses CPT code 3170F?
CPT 3170F is used by Oncology, Hematology, Pathology. Quality metric tracking appropriate baseline diagnostic testing in hematologic malignancy patients before chemotherapy or other cancer-directed therapy.
When is CPT 3170F used?
Quality metric tracking appropriate baseline diagnostic testing in hematologic malignancy patients before chemotherapy or other cancer-directed therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.